Table 7 Treatment recommendations:
From: Chemotherapy in advanced bladder cancer: current status and future
First line treatment | Second and third line treatments | ||
|---|---|---|---|
Patients eligible to cisplatin | Unfit patients | Cisplatin sensitive disease | Cisplatin refractory disease |
MVAC, HD-MVAC, GC, and DD-GC | GCa and MCAVI | Cisplatin based doublet not used in first line | Vinflunine, Paclitaxel-Gemcitabine, and all actives drugs not used |